van Dijk M C, Boers W, Linthorst C, van Berkel T J
Division of Biopharmaceutics, Sylvius Laboratory, University of Leiden, The Netherlands.
Biochem J. 1992 Oct 15;287 ( Pt 2)(Pt 2):447-55. doi: 10.1042/bj2870447.
Alpha 2-Macroglobulin (alpha 2M) requires activation by small nucleophiles (e.g. methylamine; giving alpha 2M-Me) or proteolytic enzymes (e.g. trypsin; giving alpha 2M-Tr) in order to be rapidly removed from the circulation by the liver. Separation of rat liver cells into parenchymal, endothelial and Kupffer cells at 10 min after injection indicates that liver uptake of alpha 2M-Me is shared between parenchymal and endothelial cells, with relative contributions of 51.3% and 48.3% respectively of total liver-associated radioactivity. In contrast, alpha 2M-Tr is almost exclusively taken up by the parenchymal cells (90.1% of liver-associated radioactivity). A preinjection of 5 mg of poly(inosinic acid) decreased liver uptake of alpha 2M-Me to 39.9% of the control value, while it had no effect on liver uptake of alpha 2M-Tr. It appears that poly(inosinic acid) specifically reduces the uptake of alpha 2M-Me in vivo by endothelial cells, leaving uptake by parenchymal cells unaffected. In vitro studies with isolated liver cells indicate that the association of alpha 2M-Me with endothelial cells is 21-fold higher per mg of cell protein than with parenchymal cells. The capacity of endothelial cells to degrade alpha 2M-Me appears to be 46 times higher than that of parenchymal cells. Competition studies show that poly(inosinic acid) or acetylated low-density lipoprotein effectively competes with the association of alpha 2M-Me with endothelial and Kupffer cells, but association with parenchymal cells is unaffected. It is suggested that activation of alpha 2M by methylamine induces a charge distribution on the protein which triggers specific uptake by the scavenger receptor on endothelial cells. It is concluded that the uptake of alpha 2M-Me by the scavenger receptor might function as an additional system for the uptake of activated alpha 2M.
α2-巨球蛋白(α2M)需要被小分子亲核试剂(如甲胺;生成α2M-Me)或蛋白水解酶(如胰蛋白酶;生成α2M-Tr)激活,以便能被肝脏迅速从循环中清除。注射后10分钟将大鼠肝细胞分离为实质细胞、内皮细胞和库普弗细胞,结果表明α2M-Me在肝脏的摄取是由实质细胞和内皮细胞共同完成的,分别占肝脏相关放射性总量的51.3%和48.3%。相比之下,α2M-Tr几乎完全被实质细胞摄取(占肝脏相关放射性的90.1%)。预先注射5毫克聚肌苷酸可使α2M-Me的肝脏摄取量降至对照值的39.9%,而对α2M-Tr的肝脏摄取没有影响。看来聚肌苷酸在体内能特异性降低内皮细胞对α2M-Me的摄取,而实质细胞的摄取不受影响。对分离的肝细胞进行的体外研究表明,每毫克细胞蛋白中α2M-Me与内皮细胞的结合比与实质细胞的结合高21倍。内皮细胞降解α2M-Me的能力似乎比实质细胞高46倍。竞争研究表明,聚肌苷酸或乙酰化低密度脂蛋白能有效竞争α2M-Me与内皮细胞和库普弗细胞的结合,但与实质细胞的结合不受影响。有人提出,甲胺对α2M的激活会诱导蛋白质上的电荷分布,从而触发内皮细胞上清道夫受体的特异性摄取。得出的结论是,清道夫受体对α2M-Me的摄取可能作为摄取活化α2M的另一个系统发挥作用。